Breastfeeding has long been recognized not just as a timeless practice for nurturing infants but as a profound contributor to the health of both mothers and their children. In recent times, the spotlight has shifted toward breastfeeding's potential in reducing the risk of breast cancer and other
Introducing Ivan Kairatov, a biopharma expert renowned for his insights into pharmaceutical technology and innovation, particularly in research and development. Today, we're delving into a groundbreaking moment for biliary tract cancer treatment with the conditional approval of Jazz
A new study centered around planned cesarean sections (C-sections) and their association with childhood leukemia sparks significant discussions. With rising rates of elective C-sections globally, healthcare professionals and policymakers are intrigued by findings suggesting heightened risks for
In this engaging conversation with biopharma expert Ivan Kairatov, we delve into the complexities and innovations in treating brain metastases from ovarian cancer. Ivan shares insights from a recent study that evaluated the effectiveness of Gamma Knife Stereotactic Radiosurgery (GKSRS) in managing
The landscape of cancer treatment has undergone a dynamic transformation, propelling the field towards more personalized methodologies aimed at improving patient outcomes. This evolution is largely informed by the recognition that cancer is not a monolithic disease but a complex network of
Ovarian cancer remains a formidable challenge in the medical community due to its elusive nature and high fatality rate. With approximately 75% of cases detected at later stages, patients often face dire prognoses. Current diagnostic methods are largely insufficient, typically identifying the
